1/2 SHORT COMMUNICATION Acneiform Lesions but not Acne after Treatment with Janus Kinase Inhibitors: Diagnosis and ActaDV Management of Janus Kinase-acne Fabienne BALLANGER1, Nicole AUFFRET2, Marie-Thérèse LECCIA3, Jean Paul CLAUDEL4 and Brigitte DRÉNO5* 1...
More
1/2 SHORT COMMUNICATION Acneiform Lesions but not Acne after Treatment with Janus Kinase Inhibitors: Diagnosis and ActaDV Management of Janus Kinase-acne Fabienne BALLANGER1, Nicole AUFFRET2, Marie-Thérèse LECCIA3, Jean Paul CLAUDEL4 and Brigitte DRÉNO5* 1 Private practice, Talence, 2Private practice, Paris, 3Department of Dermatology, Allergology and Photobiology, CHU A Michallon, Grenoble, 4 Private practice, Tours and 5Nantes University, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/ EMR6001, FR-44000 Nantes, France. *E-mail: brigitte.dreno@atlanmed.fr Accepted May 10, 2023; Published Jun 22, 2023 Acta Derm Venereol 2023; 103: adv11657. DOI: 10.2340/actadv.v103.11657 Acta Dermato-Venereologica The Janus kinase/signal transducer and activator of Guo et al. (9) performed a meta-analysis of the safety transcription (JAK/STAT) signalling pathway has been of JAKi based on 7 studies including 3 clinical trials linked to the pathogenesis of many inflammatory s
Less
